Literature DB >> 30390816

Skeletal Manifestations of Hypoparathyroidism.

Mishaela R Rubin1.   

Abstract

Chronic parathyroid hormone (PTH) deficiency has a marked effect on the skeleton, leading to characteristic decreases in bone remodeling and increases in bone mass. Numerous lines of evidence using biochemical, imaging, and histomorphometric methodologies have demonstrated that the skeleton is altered when PTH is absent and that these abnormalities might be reversed with PTH treatment. More evidence is needed to determine whether fracture risk is altered in hypoparathyroidism.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone; Histomorphometry; Hypoparathyroidism; Imaging; rhPTH(1-84)

Mesh:

Substances:

Year:  2018        PMID: 30390816     DOI: 10.1016/j.ecl.2018.07.008

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  3 in total

Review 1.  Hypoparathyroidism.

Authors:  John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2020-06-01       Impact factor: 5.958

Review 2.  Teriparatide administration by the Omnipod pump: preliminary experience from two cases with refractory hypoparathyroidism.

Authors:  Karine Aouchiche; Rachel Reynaud; Vincent Amodru; Thierry Brue; Thomas Cuny
Journal:  Endocrine       Date:  2022-01-04       Impact factor: 3.925

3.  Added Value of Impact Microindentation in the Evaluation of Bone Fragility: A Systematic Review of the Literature.

Authors:  Manuela Schoeb; Neveen A T Hamdy; Frank Malgo; Elizabeth M Winter; Natasha M Appelman-Dijkstra
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-07       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.